(1S)-1-(2,2-DIFLUOROBENZO[D]1,3-DIOXOLEN-4-YL)ETHYLAMINE, 95.0%, 250mg

1,3-Benzoxazol-6-ol, 98%, 500mg

3-(Pyridin-3-yl)prop-2-yn-1-ol, 95+%, 250mg

(2R,3R,4R,5S)-1,6-Bis(hexadecylamino)hexane-2,3,4,5-tetraol, 98%, 1g

L-Alanyl-L-leucine, 98%, 2.5g

N-Butyl-N'-isopropyl ethylenediamine, 98.0%, 1g

1-Bromo-4-butoxy-2,3-difluorobenzene, 95.0%, 1g

Achromatic 10x/0.25 DIN objective. Parafocal 45 mm

2-azaspiro[3.3]heptane hydrobromide, 95.0%, 1g

9,9'-Bianthracene, 95.0%, 5g

N-Cyclohexylsulfamic Acid>98.0%(T)25g

ethyl 1-ethylpiperidine-4-carboxylate, 95.0%, 25g

Benzyl (1-(tert-butyl)-3-((1S,3R)-3-hydroxycyclopentyl)-1H-pyrazol-5-yl)carbamate, 98%, 250mg